Anaptysbio (ANAB) Profit After Tax (2016 - 2026)
Anaptysbio (ANAB) posted Profit After Tax of -$53.0 million for Q1 2026, down 206.84% on a QoQ basis from $49.6 million in Q4 2025, and down 34.28% year-over-year from -$80.7 million in Q1 2025.
Anaptysbio (ANAB) Profit After Tax (2016 - 2026) Analysis & Trends
Anaptysbio's Profit After Tax history runs 11 years deep, the most recent figure standing at -$53.0 million for Q1 2026.
- Quarterly Profit After Tax fell 34.28% year-over-year to -$53.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$26.9 million (up 80.72% YoY) and the FY2025 annual result came in at -$13.2 million, up 90.89% from the prior year.
- Profit After Tax was -$53.0 million for Q1 2026 at Anaptysbio, down from $49.6 million in the prior quarter.
- Across five years, Profit After Tax topped out at $49.6 million in Q4 2025 and bottomed at -$53.0 million in Q1 2026.
- A 5-year average of -$29.4 million and a median of -$37.3 million in 2023 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2022 — Profit After Tax tumbled 7488.34% — and 2025, when it jumped 327.75%.
- Anaptysbio's Profit After Tax stood at -$20.8 million in 2022, then plunged by 102.66% to -$42.2 million in 2023, then surged by 48.39% to -$21.8 million in 2024, then soared by 327.75% to $49.6 million in 2025, then plunged by 206.84% to -$53.0 million in 2026.
- Business Quant data shows ANAB's Profit After Tax at -$53.0 million in Q1 2026, $49.6 million in Q4 2025, and $15.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Anaptysbio | 1.58 Bn | 1.29 Bn | - | -53.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -53.01 Mn |
| Dec 31, 2025 | 49.61 Mn |
| Sep 30, 2025 | 15.11 Mn |
| Jun 30, 2025 | -38.63 Mn |
| Mar 31, 2025 | -39.47 Mn |
| Dec 31, 2024 | -21.78 Mn |
| Sep 30, 2024 | -31.68 Mn |
| Jun 30, 2024 | -46.66 Mn |
| Mar 31, 2024 | -43.94 Mn |
| Dec 31, 2023 | -42.21 Mn |
| Sep 30, 2023 | -37.31 Mn |
| Jun 30, 2023 | -39.85 Mn |
| Mar 31, 2023 | -44.26 Mn |
| Dec 31, 2022 | -20.83 Mn |
| Sep 30, 2022 | -35.65 Mn |
| Jun 30, 2022 | -32.55 Mn |
| Mar 31, 2022 | -36.26 Mn |
| Dec 31, 2021 | -32.96 Mn |
| Sep 30, 2021 | -6.69 Mn |
| Jun 30, 2021 | -429,000.00 |